2m 2m 2m 2m 2m 2m 2m
Lotus Pharma (LTUS)
OTC
$0.004+$0.0010 (+31.67%)
Price as of Jul 29, 2026- N/AMarket Cap
- -35.88%1-Year Change
- Shell CompaniesIndustry
Lotus Pharma (LTUS)
$0.004+$0.0010 (+31.67%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 34
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.004
$0.004
$0.004
1-Year Range
$0.002
$0.009
$0.004
Latest Close$0.004
Change
+$0.0010 (+24.05%)
Volume325
Information as of 07/29/2026
Company Profile
LOTUS PHARMACEUTICALS INC
https://lotuspharmaceuticalsusa.comN/A
Market Cap
N/A
Net Income
Sector: Financial Services
Industry: Shell Companies
127 Leafy Twig, Irvine, CA, United States, 92618
949 591 3688Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.
Key Executives
- Zhong Yi Liu
- Yan Zeng
- Xing Shen
Current Ownership Distribution
- Other27.3M (99.66%)
- Insiders94,200 (0.34%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)